Specifically, kaempferol causes a blockage in the G2/M phase of human ovarian cancer cells by means of the Chk2/Cdc25C/Cdc2 pathway and the Chk2/p21/Cdc2 pathway. The gene discussed is CDKN1A; the disease is ovarian carcinoma.